Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ

Cell

Volumn 93, Issue 2, 1998, Pages 229-240

  Nagy, Laszlo ^a,b   Tontonoz, Peter ^a,c   Alvarez, Jacqueline G A ^a   Chen, Hongwu ^a   Evans, Ronald M ^a,b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA 12,14 PROSTAGLANDIN J 2; CD14 ANTIGEN; CD36 ANTIGEN; CORIOLIC ACID; DIMORPHECOLIC ACID; LG 268; LIGAND; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN J2; SCAVENGER RECEPTOR; TROGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; FOAM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; MACROPHAGE; PRIORITY JOURNAL;

EID: 0032540325     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81574-3     Document Type: Article

References (48)

1. Acton, S., Rigotti, A., Landshultz, K.T., Xu, S., Hobbs, H.H., and Krieger, M. (1996). Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271, 518-520.
2. Boehm, M., Zhang, L., Zhi, L., McClurg, M., Berger, E., Wagoner, M., Mais, D., Suto, C., Davies, J., Heyman, R., et al. (1995). Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J. Med. Chem. 38, 3146-3155.
3. Brown, M.S., and Goldstein, J.L. (1983). Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52, 223-261.
4. Buja, L.M., Kita, T., Goldstein, J.L., Watanabe, Y., and Brown, M.S. (1983). Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia. Arteriosclerosis 3, 87-101.
5. Chawla, A., Schwarz, E.J., Dimaculangan, D.D., and Lazar, M.A. (1994). Peroxisome proliferator-activated receptor (PPAR) γ: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135, 798-800.
6. Endemann, G., Stanton, L.W., Madden, K.S., Bryant, C.M., White, R.T., and Protter, A.A. (1993). CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268, 11811-11816.
7. Evans, R.M. (1988). The steroid and thyroid hormone receptor super-family. Science 240, 889-895.
8. Folcik, V.A., Nivar-Aristy, R.A., Krajewski, L.P., and Cathcart, M.K. (1995). Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J. Clin. Invest. 96, 504-510.
9. Fong, L., Fong, T., and Cooper, A. (1991). Inhibition of lipopolysaccharide induced IL-1β mRNA expression in mouse macrophages by oxidized low density lipoprotein. J. Lipid Res. 32, 1899-1910.
10. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803-812.
11. Forman, B.M., Chen, J., and Evans, R. (1997). Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc. Natl. Acad. Sci. USA 94, 4312-4317.
12. Glavind, J., Hartman, S., Clemmesen, J., Jessen, K., and Dam, H. (1952). Studies on the role of lopoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta. APMIS (Copenhagen) 30, 1-6.
13. Goldstein, J.L., and Brown, M.S. (1974). Binding and degradation of low density lipoprotein by cultured human fibroblasts. J. Biol. Chem. 249, 5154-5162.
14. Goldstein, J.L., and Brown, M.S. (1977). The low-density lipoprotein pathway and its relation to atherosclerosis. Annu. Rev. Biochem. 46, 897-930.
15. Goldstein, J.L., Ho, Y.K., Basu, S.K., and Brown, M.S. (1979). Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 76, 333-337.
16. Hamilton, T., Ma, G., and Chisolm, G. (1990). Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-α mRNA in stimulated murine peritoneal macrophages. J. Immunol. 144, 2343-2350.
17. Hamilton, T., Major, J., and Chisolm, G. (1995). The effects of oxidized low density lipoprotein on inducible mouse macrophage gene expression are gene and stimulus dependent. J. Clin. Invest. 95, 2020-2027.
18. Han, J., Hajjar, D.P., Febbraio, M., and Nicholson, A.C. (1997). Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J. Biol. Chem. 272, 21654-21659.
19. Harland, W., Gilbert, J., Steel, G., and Brooks, C. (1971). Lipids of human atheroma. Atherosclerosis 13, 239-246.
20. Huang, M., Bolen, J.B., Barnwell, J.W., Shattil, S.J., and Brugge, J.S. (1991). Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn and Yes protein-tyrosine kinases in human platelets. Proc. Natl. Acad. Sci. USA 88, 7844-7848.
21. Huh, H.Y., Pearce, S.F., Yesner, L.M., Schindler, J.L., and Silverstein, R.L. (1996). Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 87, 2020-2028.
22. Jiang, C., Ting, A.T., and Seed, B. (1998). PPARγ agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86.
23. Kliewer, S.A., Umesono, K., Noonan, D.J., Heyman, R.A., and Evans, R.M. (1992). Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature 358, 771-774
24. Kliewer, S.A., Lenhard, J.M., Willson, T.M., Patel, I., Morris, D.C., and Lehmann, J.M. (1995). A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83, 813-819.
25. Kliewer, S., Sundseth, S., Jones, S., Brown, P., Wisely, G., Koble, C., Devchand, P., Wahli, W., Willson, T., Lenhard, J., and Lehman, J. (1997). Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. USA 94, 4318-4323.
26. Ku, G., Thomas, C., Akeson, A., and Jackson, R. (1992). Induction of interleukin 1 β expression from human peritoneal blood monocytederived macrophages by 9-hydroxyoctadecadienoic acid. J. Biol. Chem. 267, 14183-14188.
27. Kuhn, H., Belkner, J., Zaiss, S., Fahrenklemper, T., and Wohlfeil, S. (1994). Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 179, 1903-1911.
28. Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M., and Kliewer, S.A. (1995). An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR-γ). J. Biol. Chem. 270, 12953-12956.
29. Lehr, H.A., Krober, M., Hubner, C., Vajkoczy, P., Menger, M.D., Nolte, D., Kohlschutter, A., and Messmer, K. (1993). Stimulation of leukocyte/endothelium interaction by oxidized low-density lipoprotein in hairless mice. Involvement of CD11b/CD18 adhesion receptor complex. Lab. Invest. 68, 388-395.
30. Lenz, M., Hughes, H., Mitchell, J., Via, D., Guyton, J., Taylor, A., Gotto, A., and Smith, C. (1990). Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein. J. Lipid Res. 31, 1043-1049.
31. Lipton, B., Parthasarathy, S., Ord, V., Clinton, S., Libby, P., and Rosenfeld, M. (1995). Components of the protein fraction of oxidized low density lipoprotein stimulates interleukin-1 α production by rabbit arterial macrophage-derived foam cells. J. Lipid Res. 36, 2232-2242.
32. Malden, L., Chait, A., Raines, E., and Ross, R. (1991). The influence of oxidatively modified LDL on expression of platelet derived growth factor by human monocyte-derived macrophages. J. Biol. Chem. 266, 13901-13907.
33. Matsumoto, A., Naito, M., Itakura, H., Ikemoto, S., Asaoka, H., Hayakawa, I., Kanamori, H., Aburatani, H., Takaku, F., Susuki, H., et al. (1990). Human macrophage scavenger receptors: primary structure, expression and localization in atherosclerotic lesion. Proc. Natl. Acad. Sci. USA 87, 9133-9137.
34. Nozaki, S., Kashiwagi, H., Yamashita, S., Nakagawa, T., Kostner, B., Tomiyama, Y., Nakata, A., Ishigami, M., Miyagawa, J., KamedaTakemura, K., et al. (1995). Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J. Clin. Invest. 96, 1859-1865.
35. Ohlsson, B.G., Englund, M.C., Karlsson, A.L., Knutsen, E., Erixon, C., Skribeck, H., Liu, Y., Bondjers, G., and Wiklund, O. (1996). Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-κB to DNA and the subsequent expression of tumor necrosis factor-α and interleukin-1 β in macrophages. J. Clin. Invest. 98, 78-89.
36. Quinn, M.T., Parthasarathy, S., Fong, L.G., and Steinberg, D. (1987). Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA 84, 2995-2998.
37. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J., and Glass, C.K. (1998). The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79-82.
38. Ross, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809.
39. Simon, T., Makheja, A., and Bailey, J. (1989). Formation of 15-hydroxy-eicosatetraenoic acid (15-HETE) as the predominant eicosanoid in aortas from Watanabe heritable hyperlipidemic and cholesterol-fed rabbits. Atherosclerosis 75, 31-38.
40. Steinberg, D. (1997). Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272, 20963-20966.
41. Steinbrecher, U.P., Parthasarathy, S., Leake, D.S., Witztum, J.L., and Steinberg, D. (1984). Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA 81, 3883-3887.
42. Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Skaguchi, T., Higashi, T., Suzuki, T., et al. (1997). A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386, 292-296.
43. Thomas, C., and Jackson, R. (1991). Lipid hydroperoxyde involvement in copper-dependent and independent oxidation of lowdensity lipoproteins. J. Pharmacol. Exp. Ther. 256, 1182-1188.
44. Thomas, C., Jackson, R., Ohlweiler, D., and Ku, G. (1994). Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 β release from human blood mononuclear cells. J. Lipid Res. 35, 417-427.
45. Tontonoz, P., Hu, E., Graves, R.A., Budavari, A.I., and Spiegelman, B.M. (1994a). mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234.
46. Tontonoz, P., Hu, E., and Spiegelman, B.M. (1994b). Stimulation of adipogenesis in fibroblasts by PPAPγ2, a lipid-activated transcription factor. Cell 79, 1147-1156.
47. Tontonoz, P., Nagy, L., Alvarez, J.G.A., Thomazy, V.A., and Evans, R.M. (1998). PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, this issue, 241-252.
48. Yla-Herttuala, S., Palinski, W., Rosenfeld, M.E., Parthasarathy, S., Carew, I.E., Butler, S., Witztum, J.L., and Steinberg, D. (1989). Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84, 1086-1095.